aluates Reports

$ 0.0

Automative

Global Repurposed Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-25R5737

Global Repurposed Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Repurposed Drugs Market Research Report 2025

Code: QYRE-Auto-25R5737

Report

July 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

TEVA

Novartis

Mylan NV

Johnson & Johnson

Pfizer Inc

Bausch Health

GSK

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

Repurposed Drugs Market Size

The global market for Repurposed Drugs was valued at US$ 18150 million in the year 2024 and is projected to reach a revised size of US$ 31580 million by 2031, growing at a CAGR of 8.4% during the forecast period.

Repurposed Drugs Market

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Repurposed Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Repurposed Drugs.

The Repurposed Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Repurposed Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Repurposed Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Repurposed Drugs Market Report

Report Metric	Details
Report Name	Repurposed Drugs Market
Accounted market size in year	US$ 18150 million
Forecasted market size in 2031	US$ 31580 million
CAGR	8.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Generic Drugs Clinical Trial Failed Drugs
Segment by Application	Cardiovascular Diseases Mental Illness Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Repurposed Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Repurposed Drugs Market growing?

Ans: The Repurposed Drugs Market witnessing a CAGR of 8.4% during the forecast period 2025-2031.

What is the Repurposed Drugs Market size in 2031?

Ans: The Repurposed Drugs Market size in 2031 will be US$ 31580 million.

Who are the main players in the Repurposed Drugs Market report?

Ans: The main players in the Repurposed Drugs Market are Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma

What are the Application segmentation covered in the Repurposed Drugs Market report?

Ans: The Applications covered in the Repurposed Drugs Market report are Cardiovascular Diseases, Mental Illness, Cancer, Other

What are the Type segmentation covered in the Repurposed Drugs Market report?

Ans: The Types covered in the Repurposed Drugs Market report are Generic Drugs, Clinical Trial Failed Drugs

Recommended Reports

Drug Market Segments

Clinical Trials & Delivery

Pharmaceutical & Healthcare

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Repurposed Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Generic Drugs

1.2.3 Clinical Trial Failed Drugs

1.3 Market by Application

1.3.1 Global Repurposed Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cardiovascular Diseases

1.3.3 Mental Illness

1.3.4 Cancer

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Repurposed Drugs Market Perspective (2020-2031)

2.2 Global Repurposed Drugs Growth Trends by Region

2.2.1 Global Repurposed Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Repurposed Drugs Historic Market Size by Region (2020-2025)

2.2.3 Repurposed Drugs Forecasted Market Size by Region (2026-2031)

2.3 Repurposed Drugs Market Dynamics

2.3.1 Repurposed Drugs Industry Trends

2.3.2 Repurposed Drugs Market Drivers

2.3.3 Repurposed Drugs Market Challenges

2.3.4 Repurposed Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Repurposed Drugs Players by Revenue

3.1.1 Global Top Repurposed Drugs Players by Revenue (2020-2025)

3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Repurposed Drugs Revenue

3.4 Global Repurposed Drugs Market Concentration Ratio

3.4.1 Global Repurposed Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Repurposed Drugs Revenue in 2024

3.5 Global Key Players of Repurposed Drugs Head office and Area Served

3.6 Global Key Players of Repurposed Drugs, Product and Application

3.7 Global Key Players of Repurposed Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Repurposed Drugs Breakdown Data by Type

4.1 Global Repurposed Drugs Historic Market Size by Type (2020-2025)

4.2 Global Repurposed Drugs Forecasted Market Size by Type (2026-2031)

5 Repurposed Drugs Breakdown Data by Application

5.1 Global Repurposed Drugs Historic Market Size by Application (2020-2025)

5.2 Global Repurposed Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Repurposed Drugs Market Size (2020-2031)

6.2 North America Repurposed Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Repurposed Drugs Market Size by Country (2020-2025)

6.4 North America Repurposed Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Repurposed Drugs Market Size (2020-2031)

7.2 Europe Repurposed Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Repurposed Drugs Market Size by Country (2020-2025)

7.4 Europe Repurposed Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Repurposed Drugs Market Size (2020-2031)

8.2 Asia-Pacific Repurposed Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Repurposed Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Repurposed Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Repurposed Drugs Market Size (2020-2031)

9.2 Latin America Repurposed Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Repurposed Drugs Market Size by Country (2020-2025)

9.4 Latin America Repurposed Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Repurposed Drugs Market Size (2020-2031)

10.2 Middle East & Africa Repurposed Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Repurposed Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Repurposed Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Repurposed Drugs Introduction

11.1.4 Teva Revenue in Repurposed Drugs Business (2020-2025)

11.1.5 Teva Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Repurposed Drugs Introduction

11.2.4 Novartis Revenue in Repurposed Drugs Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Mylan

11.3.1 Mylan Company Details

11.3.2 Mylan Business Overview

11.3.3 Mylan Repurposed Drugs Introduction

11.3.4 Mylan Revenue in Repurposed Drugs Business (2020-2025)

11.3.5 Mylan Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Repurposed Drugs Introduction

11.4.4 Johnson & Johnson Revenue in Repurposed Drugs Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Repurposed Drugs Introduction

11.5.4 Pfizer Revenue in Repurposed Drugs Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Details

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Repurposed Drugs Introduction

11.6.4 Bausch Health Revenue in Repurposed Drugs Business (2020-2025)

11.6.5 Bausch Health Recent Development

11.7 GSK

11.7.1 GSK Company Details

11.7.2 GSK Business Overview

11.7.3 GSK Repurposed Drugs Introduction

11.7.4 GSK Revenue in Repurposed Drugs Business (2020-2025)

11.7.5 GSK Recent Development

11.8 ChemRar Group

11.8.1 ChemRar Group Company Details

11.8.2 ChemRar Group Business Overview

11.8.3 ChemRar Group Repurposed Drugs Introduction

11.8.4 ChemRar Group Revenue in Repurposed Drugs Business (2020-2025)

11.8.5 ChemRar Group Recent Development

11.9 Glenmark

11.9.1 Glenmark Company Details

11.9.2 Glenmark Business Overview

11.9.3 Glenmark Repurposed Drugs Introduction

11.9.4 Glenmark Revenue in Repurposed Drugs Business (2020-2025)

11.9.5 Glenmark Recent Development

11.10 Fujifilm

11.10.1 Fujifilm Company Details

11.10.2 Fujifilm Business Overview

11.10.3 Fujifilm Repurposed Drugs Introduction

11.10.4 Fujifilm Revenue in Repurposed Drugs Business (2020-2025)

11.10.5 Fujifilm Recent Development

11.11 Dr. Reddy

11.11.1 Dr. Reddy Company Details

11.11.2 Dr. Reddy Business Overview

11.11.3 Dr. Reddy Repurposed Drugs Introduction

11.11.4 Dr. Reddy Revenue in Repurposed Drugs Business (2020-2025)

11.11.5 Dr. Reddy Recent Development

11.12 R-Pharma

11.12.1 R-Pharma Company Details

11.12.2 R-Pharma Business Overview

11.12.3 R-Pharma Repurposed Drugs Introduction

11.12.4 R-Pharma Revenue in Repurposed Drugs Business (2020-2025)

11.12.5 R-Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

TEVA

Novartis

Mylan NV

Johnson & Johnson

Pfizer Inc

Bausch Health

GSK

ChemRar Group

Glenmark

Fujifilm

Dr. Reddy

R-Pharma

List of Tables

Table 1. Global Repurposed Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Generic Drugs

Table 3. Key Players of Clinical Trial Failed Drugs

Table 4. Global Repurposed Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Repurposed Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Repurposed Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Repurposed Drugs Market Share by Region (2020-2025)

Table 8. Global Repurposed Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Repurposed Drugs Market Share by Region (2026-2031)

Table 10. Repurposed Drugs Market Trends

Table 11. Repurposed Drugs Market Drivers

Table 12. Repurposed Drugs Market Challenges

Table 13. Repurposed Drugs Market Restraints

Table 14. Global Repurposed Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Repurposed Drugs Market Share by Players (2020-2025)

Table 16. Global Top Repurposed Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repurposed Drugs as of 2024)

Table 17. Ranking of Global Top Repurposed Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Repurposed Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Repurposed Drugs, Headquarters and Area Served

Table 20. Global Key Players of Repurposed Drugs, Product and Application

Table 21. Global Key Players of Repurposed Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Repurposed Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Repurposed Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Repurposed Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Repurposed Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Repurposed Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Repurposed Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Repurposed Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Repurposed Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Repurposed Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Repurposed Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Repurposed Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Repurposed Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Repurposed Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Repurposed Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Repurposed Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Repurposed Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Repurposed Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Repurposed Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Repurposed Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Repurposed Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Repurposed Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Repurposed Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Repurposed Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Teva Company Details

Table 47. Teva Business Overview

Table 48. Teva Repurposed Drugs Product

Table 49. Teva Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 50. Teva Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Repurposed Drugs Product

Table 54. Novartis Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Mylan Company Details

Table 57. Mylan Business Overview

Table 58. Mylan Repurposed Drugs Product

Table 59. Mylan Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 60. Mylan Recent Development

Table 61. Johnson & Johnson Company Details

Table 62. Johnson & Johnson Business Overview

Table 63. Johnson & Johnson Repurposed Drugs Product

Table 64. Johnson & Johnson Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 65. Johnson & Johnson Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Repurposed Drugs Product

Table 69. Pfizer Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 70. Pfizer Recent Development

Table 71. Bausch Health Company Details

Table 72. Bausch Health Business Overview

Table 73. Bausch Health Repurposed Drugs Product

Table 74. Bausch Health Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 75. Bausch Health Recent Development

Table 76. GSK Company Details

Table 77. GSK Business Overview

Table 78. GSK Repurposed Drugs Product

Table 79. GSK Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 80. GSK Recent Development

Table 81. ChemRar Group Company Details

Table 82. ChemRar Group Business Overview

Table 83. ChemRar Group Repurposed Drugs Product

Table 84. ChemRar Group Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 85. ChemRar Group Recent Development

Table 86. Glenmark Company Details

Table 87. Glenmark Business Overview

Table 88. Glenmark Repurposed Drugs Product

Table 89. Glenmark Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 90. Glenmark Recent Development

Table 91. Fujifilm Company Details

Table 92. Fujifilm Business Overview

Table 93. Fujifilm Repurposed Drugs Product

Table 94. Fujifilm Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 95. Fujifilm Recent Development

Table 96. Dr. Reddy Company Details

Table 97. Dr. Reddy Business Overview

Table 98. Dr. Reddy Repurposed Drugs Product

Table 99. Dr. Reddy Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 100. Dr. Reddy Recent Development

Table 101. R-Pharma Company Details

Table 102. R-Pharma Business Overview

Table 103. R-Pharma Repurposed Drugs Product

Table 104. R-Pharma Revenue in Repurposed Drugs Business (2020-2025) & (US$ Million)

Table 105. R-Pharma Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Repurposed Drugs Picture

Figure 2. Global Repurposed Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Repurposed Drugs Market Share by Type: 2024 VS 2031

Figure 4. Generic Drugs Features

Figure 5. Clinical Trial Failed Drugs Features

Figure 6. Global Repurposed Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Repurposed Drugs Market Share by Application: 2024 VS 2031

Figure 8. Cardiovascular Diseases Case Studies

Figure 9. Mental Illness Case Studies

Figure 10. Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Repurposed Drugs Report Years Considered

Figure 13. Global Repurposed Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Repurposed Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Repurposed Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Repurposed Drugs Market Share by Players in 2024

Figure 17. Global Top Repurposed Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repurposed Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Repurposed Drugs Revenue in 2024

Figure 19. North America Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Repurposed Drugs Market Share by Country (2020-2031)

Figure 21. United States Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Repurposed Drugs Market Share by Country (2020-2031)

Figure 25. Germany Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Repurposed Drugs Market Share by Region (2020-2031)

Figure 33. China Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Repurposed Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Repurposed Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Repurposed Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Teva Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 50. Mylan Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 53. Bausch Health Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 54. GSK Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 55. ChemRar Group Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 56. Glenmark Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 57. Fujifilm Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 58. Dr. Reddy Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 59. R-Pharma Revenue Growth Rate in Repurposed Drugs Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Repositioning Market Insights Forecast to 2030

Global Drug Repurposing Market Research Report 2024

Global Drug Repurposing Serveice Market Research Report 2025

Outsourced Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Reprofiling Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Refurbished Medical Imaging Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Used and Refurbished Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Remanufactured Medical Imaging Device Market Research Report 2025

Global Patient Repositioning System Market Research Report 2024

Refurbished Laboratory Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hormone Replacement Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Reverse Logistics Service Market Research Report 2024

Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Reconstitution System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Regenerative Drugs Market Insights Forecast to 2030

Global Medication Therapy Management Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions